Tandem Diabetes Care, Inc.
NASDAQTandem Diabetes Care is caught between two competing forces this week — short sellers keep reducing exposure, yet the stock has given back nearly 9% over the past five sessions to close at $21.58. The short-covering trend noted in our August 22 note has continued. Short interest dropped a further 4% on Tuesday alone, bringing the total down to 10.34 million shares, or 15.2% of the…
TNDM short interest surges 34% in a week to 19% of float, driven by mounting bearish sentiment on earnings disappointment and competitive headwinds.
Tandem Diabetes Care is caught between two competing forces this week — short sellers keep reducing exposure, yet the stock has given back nearly 9% over the past five sessions to close at $21.58. The short-covering…
Tandem Diabetes Care heads into the back half of August with a notable split in momentum — a 27% one-month rally has prompted fresh analyst attention while short sellers quietly but consistently pare back…
Snapshot as of 23 Sept 2026
Tandem Diabetes Care delivered one of the week's more dramatic squeeze setups — a heavily shorted stock that jumped 19% in a single session after earnings, leaving nearly 19% of the float still betting against it. The…
Tandem Diabetes Care reports first-quarter results on May 20 with the stock deep in a drawdown — down 39% over the past month and 17% in the past week alone to close at $12.82. The damage follows a punishing Q4-style…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for TNDM — free to start on ORTEX.
Sign up for free →Open TNDM on ORTEX